InsiderTrades

Form 4 for GOSS Gossamer Bio, Inc.

Accepted 2023-03-22 00:00:00 ET · period of report 2023-03-20 · accession 0001728117-23-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2023-03-22 2023-03-20+ GOSS Hasnain Faheem Pres, CEO, Dir P - Purchase $1.14 +878.6K 4.50M +24% +$999.2K
D 2023-03-22 2023-03-20 GOSS Hasnain Faheem Pres, CEO, Dir A - Grant $0.00 +544.5K 544.5K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-21 P A 269,389 $1.20 4,055,397 I By family trust — — (F2) This transaction was executed in multiple trades at prices ranging from $1.155 to $1.21 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
2 Common Common Stock 2023-03-20 P A 168,683 $1.03 3,786,008 I By family trust — — (F1) This transaction was executed in multiple trades at prices ranging from $0.97 to 1.09 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
3 Common Common Stock 2023-03-22 P A 440,500 $1.14 4,495,897 I By family trust — — (F3) This transaction was executed in multiple trades at prices ranging from $1.06 to $1.20 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
4 Derivative Stock Option (Right to Buy) 2023-03-20 A A 544,500 $0.00 544,500 D $1.21 · — to 2033-03-19 544,500 Common Stock (F4) 25% of the total number of shares subject to the option will vest on March 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.